118 related articles for article (PubMed ID: 20529825)
1. Role of I-TAC-binding receptors CXCR3 and CXCR7 in proliferation, activation of intracellular signaling pathways and migration of various tumor cell lines.
Miekus K; Jarocha D; Trzyna E; Majka M
Folia Histochem Cytobiol; 2010 Jan; 48(1):104-11. PubMed ID: 20529825
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
[TBL] [Abstract][Full Text] [Related]
3. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
Puchert M; Obst J; Koch C; Zieger K; Engele J
Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604
[TBL] [Abstract][Full Text] [Related]
4. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
Grymula K; Tarnowski M; Wysoczynski M; Drukala J; Barr FG; Ratajczak J; Kucia M; Ratajczak MZ
Int J Cancer; 2010 Dec; 127(11):2554-68. PubMed ID: 20162608
[TBL] [Abstract][Full Text] [Related]
5. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
6. Induction of C-X-C chemokine receptor type 7 (CXCR7) switches stromal cell-derived factor-1 (SDF-1) signaling and phagocytic activity in macrophages linked to atherosclerosis.
Ma W; Liu Y; Ellison N; Shen J
J Biol Chem; 2013 May; 288(22):15481-94. PubMed ID: 23599431
[TBL] [Abstract][Full Text] [Related]
7. CXCR7: a new SDF-1-binding receptor in contrast to normal CD34(+) progenitors is functional and is expressed at higher level in human malignant hematopoietic cells.
Tarnowski M; Liu R; Wysoczynski M; Ratajczak J; Kucia M; Ratajczak MZ
Eur J Haematol; 2010 Dec; 85(6):472-83. PubMed ID: 20887389
[TBL] [Abstract][Full Text] [Related]
8. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
[TBL] [Abstract][Full Text] [Related]
9. CXCR7 impact on CXCL12 biology and disease.
Sánchez-Martín L; Sánchez-Mateos P; Cabañas C
Trends Mol Med; 2013 Jan; 19(1):12-22. PubMed ID: 23153575
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma.
San-Miguel T; Pinto S; Navarro L; Callaghan RC; Monteagudo C; López-Ginés C; Cerdá-Nicolás M; Gil-Benso R
Pathol Oncol Res; 2015 Sep; 21(4):1191-9. PubMed ID: 26037167
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
12. Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.
Koch C; Fischer NC; Puchert M; Engele J
BMC Cancer; 2022 Dec; 22(1):1335. PubMed ID: 36539774
[TBL] [Abstract][Full Text] [Related]
13. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.
Hattermann K; Held-Feindt J; Lucius R; Müerköster SS; Penfold ME; Schall TJ; Mentlein R
Cancer Res; 2010 Apr; 70(8):3299-308. PubMed ID: 20388803
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Mir H; Kapur N; Singh R; Sonpavde G; Lillard JW; Singh S
Cell Cycle; 2016; 15(6):819-26. PubMed ID: 27029529
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
16. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.
Odemis V; Lipfert J; Kraft R; Hajek P; Abraham G; Hattermann K; Mentlein R; Engele J
Glia; 2012 Mar; 60(3):372-81. PubMed ID: 22083878
[TBL] [Abstract][Full Text] [Related]
17. The role of the SDF-1/ CXCR7 axis on the growth and invasion ability of endometrial cancer cells.
Gu HQ; Zhang ZB; Zhang JW; Wang QQ; Xi XW; He YY
Arch Gynecol Obstet; 2017 Apr; 295(4):987-995. PubMed ID: 28239742
[TBL] [Abstract][Full Text] [Related]
18. CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation.
Hu SC; Yu HS; Yen FL; Chen GS; Lan CC
Exp Dermatol; 2014 Dec; 23(12):902-8. PubMed ID: 25256412
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer.
Rupertus K; Sinistra J; Scheuer C; Nickels RM; Schilling MK; Menger MD; Kollmar O
Clin Exp Metastasis; 2014 Apr; 31(4):447-59. PubMed ID: 24493023
[TBL] [Abstract][Full Text] [Related]
20. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
